1. Home
  2. APLS vs SANM Comparison

APLS vs SANM Comparison

Compare APLS & SANM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • SANM
  • Stock Information
  • Founded
  • APLS 2009
  • SANM 1980
  • Country
  • APLS United States
  • SANM United States
  • Employees
  • APLS N/A
  • SANM N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • SANM Electrical Products
  • Sector
  • APLS Health Care
  • SANM Technology
  • Exchange
  • APLS Nasdaq
  • SANM Nasdaq
  • Market Cap
  • APLS 4.0B
  • SANM 4.2B
  • IPO Year
  • APLS 2017
  • SANM 1993
  • Fundamental
  • Price
  • APLS $30.13
  • SANM $84.18
  • Analyst Decision
  • APLS Buy
  • SANM Hold
  • Analyst Count
  • APLS 18
  • SANM 1
  • Target Price
  • APLS $46.71
  • SANM $69.00
  • AVG Volume (30 Days)
  • APLS 2.1M
  • SANM 332.9K
  • Earning Date
  • APLS 02-25-2025
  • SANM 01-27-2025
  • Dividend Yield
  • APLS N/A
  • SANM N/A
  • EPS Growth
  • APLS N/A
  • SANM N/A
  • EPS
  • APLS N/A
  • SANM 3.91
  • Revenue
  • APLS $715,216,000.00
  • SANM $7,568,328,000.00
  • Revenue This Year
  • APLS $95.82
  • SANM $10.12
  • Revenue Next Year
  • APLS $12.02
  • SANM $6.72
  • P/E Ratio
  • APLS N/A
  • SANM $21.52
  • Revenue Growth
  • APLS 162.10
  • SANM N/A
  • 52 Week Low
  • APLS $24.34
  • SANM $49.57
  • 52 Week High
  • APLS $71.90
  • SANM $86.05
  • Technical
  • Relative Strength Index (RSI)
  • APLS 44.83
  • SANM 72.98
  • Support Level
  • APLS $27.61
  • SANM $82.24
  • Resistance Level
  • APLS $30.13
  • SANM $83.58
  • Average True Range (ATR)
  • APLS 1.50
  • SANM 1.89
  • MACD
  • APLS -0.35
  • SANM 0.76
  • Stochastic Oscillator
  • APLS 33.82
  • SANM 87.97

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue primarily in the United States, China, and Mexico, but has a presence around the world.

Share on Social Networks: